J Parathyr Dis. 2018;6(2): 36-38.
doi: 10.15171/jpd.2018.14
  Abstract View: 3885
  PDF Download: 1771


The need for a reliable bone biomarker to better assess chronic kidney disease mineral and bone disorder

Ramin Tolouian 1*, Ajay Gupta 2

1 Department of Internal Medicine, Manatee Memorial Hospital, Bradenton, FL, USA.
2 Rockwell Medical, Wixom, MI, USA.
*Corresponding Author: *Corresponding author: Ramin Tolouian,, Email: Tolouian@yahoo.com


Chronic kidney disease mineral and bone disorder is a metabolic bone disease present in almost all uremic patients. There are no good markers of bone resorption available for uremic patients. The validity of parathormone as a surrogate marker of bone and mineral disorders has been questioned over the past decade. We need to shift from Surrogate markers to bone markers.
First Name
Last Name
Email Address
Security code

Abstract View: 3886

Your browser does not support the canvas element.

PDF Download: 1771

Your browser does not support the canvas element.

ePublished: 25 Sep 2017
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)